SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000935836-22-000181
Filing Date
2022-02-14
Accepted
2022-02-15 08:37:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 harpoontherapeutics13ga.htm SC 13G/A 59267
  Complete submission text file 0000935836-22-000181.txt   60854
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Subject) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90935 | Film No.: 22637139
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1 LETTERMAN DRIVE STE. D3-700 SAN FRANCISCO CA 94129
Business Address 1 LETTERMAN DRIVE STE. D3-700 SAN FRANCISCO CA 94129 4158014660
Logos Global Management LP (Filed by) CIK: 0001792126 (see all company filings)

IRS No.: 833997742 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A